C-S5SWShip of Theseus
HOX biologics, degradation resistance, transcription factors
modulatingbiologic
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-S5SW
C-S5SWC-S5SWHOX biologics, degradation resistance, transcription factors
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Ship of Theseus HOX biologics, degradation resistance, transcription factors
Ship of Theseus develops biologics based on the homeobox family of transcription factors. The company modifies conserved domains of HOX proteins so the molecules avoid intracellular degradation and can be used as pharmaceuticals without frequent repeat dosing. Its disclosed programs and grants reference chronic wound healing, neutropenia recovery, stem cell expansion, and a tandem CAR-T/HSC transplantation platform.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Ship of Theseus — Early mechanism · Lower middle. Derived deterministically from 4 extracted project(s). Most-advanced status: preclinical. Band: early_mechanism. Modifiers: +5 depth (4 programs at preclinical).…
Source: Deterministic